Altered Sex Differences in Hippocampal Subfield Volumes in Schizophrenia.

bipolar disorders hippocampus neuroimaging schizophrenia sex differences

Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
24 Jun 2023
Historique:
medline: 24 6 2023
pubmed: 24 6 2023
entrez: 24 6 2023
Statut: aheadofprint

Résumé

The hippocampus is a heterogenous brain structure that differs between the sexes and has been implicated in the pathophysiology of psychiatric illnesses. Here, we explored sex and diagnostic group differences in hippocampal subfield volumes, in individuals with schizophrenia spectrum disorder (SZ), bipolar disorders (BD), and healthy controls (CTL). One thousand and five hundred and twenty-one participants underwent T1-weighted magnetic resonance imaging (SZ, n = 452, mean age 30.7 ± 9.2 [SD] years, males 59.1%; BD, n = 316, 33.7 ± 11.4, 41.5%; CTL, n = 753, 34.1 ± 9.1, 55.6%). Total hippocampal, subfield, and intracranial volumes were estimated with Freesurfer (v6.0.0). Analysis of covariance and multiple regression models were fitted to examine sex-by-diagnostic (sub)group interactions in volume. In SZ and BD, separately, associations between volumes and clinical as well as cognitive measures were examined between the sexes using regression models. Significant sex-by-group interactions were found for the total hippocampus, dentate gyrus, molecular layer, presubiculum, fimbria, hippocampal-amygdaloid transition area, and CA4, indicating a larger volumetric deficit in male patients relative to female patients when compared with same-sex CTL. Subgroup analyses revealed that this interaction was driven by males with schizophrenia. Effect sizes were overall small (partial η < 0.02). We found no significant sex differences in the associations between hippocampal volumes and clinical or cognitive measures in SZ and BD. Using a well-powered sample, our findings indicate that the pattern of morphological sex differences in hippocampal subfields is altered in individuals with schizophrenia relative to CTL, due to higher volumetric deficits in males.

Sections du résumé

BACKGROUND AND HYPOTHESIS OBJECTIVE
The hippocampus is a heterogenous brain structure that differs between the sexes and has been implicated in the pathophysiology of psychiatric illnesses. Here, we explored sex and diagnostic group differences in hippocampal subfield volumes, in individuals with schizophrenia spectrum disorder (SZ), bipolar disorders (BD), and healthy controls (CTL).
STUDY DESIGN METHODS
One thousand and five hundred and twenty-one participants underwent T1-weighted magnetic resonance imaging (SZ, n = 452, mean age 30.7 ± 9.2 [SD] years, males 59.1%; BD, n = 316, 33.7 ± 11.4, 41.5%; CTL, n = 753, 34.1 ± 9.1, 55.6%). Total hippocampal, subfield, and intracranial volumes were estimated with Freesurfer (v6.0.0). Analysis of covariance and multiple regression models were fitted to examine sex-by-diagnostic (sub)group interactions in volume. In SZ and BD, separately, associations between volumes and clinical as well as cognitive measures were examined between the sexes using regression models.
STUDY RESULTS RESULTS
Significant sex-by-group interactions were found for the total hippocampus, dentate gyrus, molecular layer, presubiculum, fimbria, hippocampal-amygdaloid transition area, and CA4, indicating a larger volumetric deficit in male patients relative to female patients when compared with same-sex CTL. Subgroup analyses revealed that this interaction was driven by males with schizophrenia. Effect sizes were overall small (partial η < 0.02). We found no significant sex differences in the associations between hippocampal volumes and clinical or cognitive measures in SZ and BD.
CONCLUSIONS CONCLUSIONS
Using a well-powered sample, our findings indicate that the pattern of morphological sex differences in hippocampal subfields is altered in individuals with schizophrenia relative to CTL, due to higher volumetric deficits in males.

Identifiants

pubmed: 37354490
pii: 7206873
doi: 10.1093/schbul/sbad091
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Research Council of Norway
ID : 223273
Organisme : South-Eastern Norway Regional Health Authority
ID : 2017097
Organisme : K. G. Jebsen Foundation
ID : SKGJ-MED-008

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.

Auteurs

Claudia Barth (C)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.

Stener Nerland (S)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.

Kjetil N Jørgensen (KN)

Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.
Department of Psychiatry, Telemark Hospital, Skien, Norway.

Beathe Haatveit (B)

Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, NORMENT, Oslo, Norway.

Laura A Wortinger (LA)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.

Ingrid Melle (I)

Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, NORMENT, Oslo, Norway.

Unn K Haukvik (UK)

Division of Mental Health and Addiction, Oslo University Hospital, NORMENT, Oslo, Norway.
Department of Adult Mental Health, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Centre of Research and Education in Forensic Psychiatry, Oslo University Hospital, Oslo, Norway.

Torill Ueland (T)

Division of Mental Health and Addiction, Oslo University Hospital, NORMENT, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Ole A Andreassen (OA)

Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, NORMENT, Oslo, Norway.

Ingrid Agartz (I)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, NORMENT, Oslo, Norway.
Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Classifications MeSH